Compounds > imatinib mesylate
Page last updated: 2024-09-03

imatinib mesylate and Short Bowel Syndrome

imatinib mesylate has been researched along with Short Bowel Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beumer, JH; Egorin, MJ; Lagattuta, TF; Natale, JJ; Raptis, A1

Trials

1 trial(s) available for imatinib mesylate and Short Bowel Syndrome

ArticleYear
Disposition of imatinib and its metabolite CGP74588 in a patient with chronic myelogenous leukemia and short-bowel syndrome.
    Pharmacotherapy, 2006, Volume: 26, Issue:7

    Topics: Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Jejunostomy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Piperazines; Pyrimidines; Short Bowel Syndrome

2006